46. Mechanick JI, Rosenson RS, Pinney SP, Mancini DM, Narula J, Fuster V. Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar. J Am Coll Cardiol . 2020;76(17):2024-2035. doi:10.1016/j.jacc.2020.07.069 47. Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review. J Am Coll Cardiol . 2020;75(5):525-538. doi:10.1016/j.jacc.2019.11.044 48. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res . 2020;191:145-147. doi:10.1016/j. thromres.2020.04.013 49. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet . 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566- 3 50. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost . 2020;18(4):844-847. doi:10.1111/jth.14768 51. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol . 2020;75(23):2950- 2973. doi:10.1016/j.jacc.2020.04.031 52. World Health Organization. “Clinical management of severe acute respiratory infection when novel coronavirus (2019- nCoV) infection is suspected. Interim guidance 28 January 2020” . Available at: https://www.who.int/docs/default- source/coronaviruse/clinical-management-of-novel-cov.pdf. (Accessed on February 2 nd , 2021) 53. Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest . 2020;158(3):1143-1163. doi:10.1016/j. chest.2020.05.559 54. American Society of Hematology. COVID-19 and VTE/ anticoagulation: frequently asked questions. 2020. Available at: https://www.hematology.org/covid-19/covid-19-and-vte- anticoagulation. Accessed February 14, 2021. 55. American Society of Hematology. Should DOACs, LMWH, UFH, Fondaparinux, Argatroban, or Bivalirudin at intermediate-intensity or therapeutic-intensity vs. prophylactic intensity be used for patients with COVID-19 related critical illness who do not have suspected or confirmed VTE? 2020. Available at: https://guidelines.ash. gradepro.org/profile/3CQ7J0SWt58. Accessed February 14, 2020 56. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines. nih.gov/. Accessed February 14, 2021 57. The American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, obstetrics. 2020. Available at: https://www.acog.org/clinical-information/ physician-faqs/covid-19-faqs-for-ob-gyns-obstetrics. Accessed February 14, 2021.
a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet . 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566- 3 33. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [published correction appears in BMJ. 2020 Mar 31;368:m1295]. BMJ . 2020;368:m1091. Published 2020 Mar 26. doi:10.1136/bmj.m1091 34. Bleakley C, Singh S, Garfield B, et al. Right ventricular dysfunction in critically ill COVID-19 ARDS [published online ahead of print, 2020 Nov 23]. Int J Cardiol . 2020;S0167- 5273(20)34166-8. doi:10.1016/j.ijcard.2020.11.043 35. Szekely Y, Lichter Y, Taieb P, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation . 2020;142(4):342-353. doi:10.1161/ CIRCULATIONAHA.120.047971 36. Li Y, Li H, Zhu S, et al. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC Cardiovasc Imaging . 2020;13(11):2287-2299. doi:10.1016/j. jcmg.2020.04.014 37. Mehra MR, Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link?. JACC Heart Fail . 2020;8(6):512-514. doi:10.1016/j. jchf.2020.03.004 38. Zhang Y, Coats AJS, Zheng Z, et al. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail . 2020;22(6):941-956. doi:10.1002/ejhf.1915 39. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published correction appears in Lancet Respir Med. 2020 Apr;8(4):e26]. Lancet Respir Med . 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5 40. Yao XH, Li TY, He ZC, et al. Zhonghua Bing Li Xue Za Zhi . 2020;49(5):411-417. doi:10.3760/ cma.j.cn112151-20200312-00193 41. Fox SE, Li G, Akmatbekov A, et al. Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation . 2020;142(11):1123-1125. doi:10.1161/ CIRCULATIONAHA.120.049465 42. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA . 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585 43. Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm . 2020;17(9):1439-1444. doi:10.1016/j.hrthm.2020.06.016 44. Chorin E, Wadhwani L, Magnani S, et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/ azithromycin. Heart Rhythm . 2020;17(9):1425-1433. doi:10.1016/j.hrthm.2020.05.014 45. Roden DM, Harrington RA, Poppas A, Russo AM. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment. Heart Rhythm . 2020;17(7):e231-e232. doi:10.1016/j.hrthm.2020.04.016
29
Made with FlippingBook Digital Publishing Software